Table 2.

The secondary outcomes of the study

Secondary outcome measures
CPET	Change in VO2 peak (ml/min/kg), change in VO2 at AT (ml/min/kg) and change in FEV1 prior and post intervention
Sarcopenia	Change in amount of L3 level skeletal muscle area determined on CT scan by methodology described by Perthen et al. [21], change in fat composition and volume measured by CT scan and change in grip strength pre and post intervention
Exercise intervention	Change of step count throughout the intervention
Oncological treatment	Number of patients with dose reductions or who terminate chemotherapy early, percentage of planned chemotherapy delivered, admissions to hospital with chemotherapy induced toxicity
Quality of life	Change of score on validated quality of life questionnaires QLQ-C30 and QLQ-OG25 pre and post intervention
Acceptability	Qualitative evidence generated from focus group discussions with participants